Navigation Links
PTC Therapeutics Reports Third Quarter 2013 Financial and Corporate Results
Date:11/14/2013

dystrophy confirmatory Phase 3 clinical trial and the initiation of our Phase 3 confirmatory trial in nonsense mutation cystic fibrosis. We also look forward to advancement of our other programs highlighted in our R&D day."

Corporate Highlights:

  • Publications in Muscle and Nerve validating six-minute walk test and describing ambulatory natural history in DMD patients: In August 2013, data published in two manuscripts in the medical journal Muscle & Nerve demonstrated the clinical meaningfulness of the six-minute walk test as a primary endpoint to measure disease progression and walking ability in ambulatory Duchenne muscular dystrophy trials.  The natural history data utilized for the analysis was obtained from PTC's Phase 2b trial of ataluren in 174 patients, the first registration–directed, placebo-controlled, multi-national study of a new chemical entity for DMD.
  • Presentations at multiple scientific conferences:  During the quarter, PTC presented at multiple scientific conferences including the European Pediatric Neurology Society Congress (EPNS), where PTC hosted a symposium titled "New perspectives in the management of Duchenne muscular dystrophy," the World Muscle Society Congress (WMS) and the North American Cystic Fibrosis Conference (NACFC). 
  • Chosen to join the Russell 2000 Index: On September 30th, PTC was added to the Russell 2000 Index.  The Russell 2000® Index, a subset of the Russell 3000® Index, measures the performance of the small-cap segment of the U.S. equity market.
  • Hosted first R&D Day: On October 25th, PTC hosted its first R&D day in New York City where PTC's senior management and research teams presented in-depth reviews of the company's scientific platforms and R&D programs.
  • Confirmatory Phase 3 Trial in nmDMD on track: In April 2013, PTC initiated a confirmatory Phase 3
    '/>"/>

  • SOURCE PTC Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Aratana Therapeutics Reports Third Quarter 2013 Financial Results
    2. Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws
    3. Argos Therapeutics to Present at the Elsevier Therapeutic Area Partnerships Meeting
    4. Mirati Therapeutics Reports Third Quarter 2013 Financial Results
    5. Sorrento Therapeutics Adopts Stockholder Rights Plan
    6. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
    7. Shield Therapeutics Files Investigational New Drug Application for ST10 for the Treatment of Iron Deficiency in Chronic Kidney Disease
    8. Cara Therapeutics Files Registration Statement for Proposed Initial Public Offering
    9. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    10. Echo Therapeutics Announces Third Quarter 2013 Financial Results
    11. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... ST. LOUIS, July 29, 2014  Express Scripts Holding ... quarter net income attributable to Express Scripts stockholders of ... per diluted share, as detailed in Table 4, was ... "We are well positioned to serve our clients with ... and to improve the health outcomes of our members," stated ...
    (Date:7/29/2014)... 29, 2014 Regado Biosciences, Inc. (Nasdaq: ... Phase 3 clinical development of Revolixys™ Kit (previously known ... today announced that it will hold a conference call ... at 8:30 a.m. EDT to discuss its second quarter ... participants and investors may access the conference call by ...
    (Date:7/29/2014)... VIEW, Calif. , July 29, 2014  Alexza ... that it is participating in two healthcare conferences during ... Conference and the Morgan Stanley Global Healthcare 2014 Conference. ... Morgan Stanley Conference.  The details on each event are ... Conference, Monday, August 11, 2014 in Boston ...
    Breaking Medicine Technology:Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 8Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 9Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 10Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 11Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 12Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 13Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 14Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 15Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 16Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 17Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 18Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 19Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 20Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 21Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 22Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 23Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 24Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 26Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 27Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 28Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 29Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 30Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 31Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 2Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3
    (Date:7/30/2014)... Francisco, CA (PRWEB) July 30, 2014 ... capture and physician communication, launched an Observation Result ... in the hospital. pMD’s cardiology customers are using ... optimize revenue for their test interpretations for electrocardiograms, ... interprets tests in the hospital, the cardiology system ...
    (Date:7/30/2014)... Regents Health Resources, a consulting firm traditionally ... care industry veteran Daryl Demonbreun and former St. Thomas ... company’s ambitious plans to grow into a full-service health ... along at a steady pace for nearly 20 years, ... says Bob Maier, founder and chief executive officer of ...
    (Date:7/29/2014)... July 30, 2014 VisitandCare.com ... have been added to the company’s exclusive network to ... out of joint efforts — as top fertility clinics ... to offer affordable, state-of-the-art, and successful IVF treatments. , ... with a comprehensive study by professionals at VisitandCare.com. The ...
    (Date:7/29/2014)... a well-known wedding dress manufacturer and retailer, has unveiled its ... this, it has announced that all of them are provided ... its old and new clients may now access the big ... are pleased to release the new collection of satin bridal ... amazing items. It is true that our satin bridal gowns ...
    (Date:7/29/2014)... Phytceramides are a natural anti-aging tool for improving skin, ... , Today is the last day to nab a free download ... The book is also sold in hard copy. , "I am ... Phytoceramides were so new and very unknown in the U.S. ... says Kathy Heshelow, founder of Sublime Beauty®. "It is an easy ...
    Breaking Medicine News(10 mins):Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 2Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 3Health News:Sferrella and Demonbreun Join Regents Health Resources 2Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:Cheap Satin Bridal Gowns Recently Provided By Well-known Supplier iFitDress.com 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 3
    ... , MINNEAPOLIS, Aug. 31 The August edition ... Lotion can play in managing dry skin associated with the genetic skin ... that 40% of women have symptoms, like little red bumps on their ... , To help individuals find out more about dry ...
    ... , Safety tips also offered as fires threaten ... American Red Cross is on the scene offering evacuees a safe place ... scorch thousands of acres. Overnight, nearly 200 people took refuge from the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , , "If ...
    ... find tumors during minimally invasive surgery, researchers say , ... arm that can gently "feel" for cancerous tumors during ... , The device, invented at the University of Western ... will help surgeons better isolate tumors from softer surrounding ...
    ... , , Union members to ... , , LOS ANGELES and OAKLAND, Calif., Aug. ... California will picket outside their work sites for the next five weeks ... pickets will take place from 11:30 a.m. to 1:30 p.m. on Tuesday, ...
    ... , , , COCONUT ... ) the leading single source telehealth solution provider and ... savings accounts for unions, employers, and brokers, announced today that ... corporations and unions, will not only revolutionize the delivery of ...
    ... NEW YORK, Aug. 31 You may guess by reading ... a rare breed. He,s also a rare blood type: O-positive, "Code ... , , Make that a VERY dedicated blood donor: ... donation, the most on record for New York Blood Center (NYBC) and ...
    Cached Medicine News:Health News:Family Circle Magazine Features AmLactin(R) in Article on Managing Dry Skin Associated With Keratosis Pilaris 2Health News:Red Cross Shelters Wildfire Evacuees 2Health News:Red Cross Shelters Wildfire Evacuees 3Health News:New Robotic Arm Has Softer Surgical Touch 2Health News:Kaiser Workers' Statewide Campaign Starts Tuesday 2Health News:e-Telmed, Inc., the Leading Telehealth Solution Provider, Signs Exclusive Agreement with Synergistic Healthcare 2Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 2Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 3Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 4
    Chlorhexidine Gluconate, exceptionally persistent and broad spectrum antimicrobial properties have led to its recognition as the most effective agent available for surgical scrubbing, hand washing, p...
    BETASEPT® Scrub 4% is for surgical handscrubbing, healthcare personnel hand-washing, preoperative patient prepping and general skin degerming....
    BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri...
    ... Biosoft plus Neu ... spectrum anti-infective alcohol hand ... added ingredients of the ... has been clinically proven ...
    Medicine Products: